Plain-English translation of NCT07184814 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that follows patients who have been diagnosed with Takayasu's arteritis—a rare condition where blood vessels in the lungs become inflamed and narrowed. Researchers want to learn more about how this condition affects different patients, what treatments work best, and which patients are at higher risk for serious complications.
Takayasu's arteritis with lung involvement is rare and not well understood, which makes it hard for doctors to predict which patients will have the worst outcomes or to catch dangerous complications like high blood pressure in the lungs early enough. This study aims to fill those knowledge gaps so doctors can help patients better.
You likely qualify if…
You likely don't qualify if…
If you qualify, researchers will review your medical records from your hospitalization and track your health information over time. You won't need to take any new medication or undergo special procedures for this study—it's purely observational, meaning doctors are gathering information about your condition and how you're doing on your current treatment plan.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China
Sponsor
China-Japan Friendship Hospital
Enrollment target
~150 participants
Started
January 2016
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Wanmu Xie, Doctor
China-Japan Friendship Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.